Patient-initiated, twice-daily oral famciclovir for early recurrent genital herpes: A randomized, double-blind multicenter trial

JAMA

Volumn 276, Issue 1, 1996, Pages 44-49

  Sacks, Stephen L ^a,f   Aoki, Fred Y ^b   Diaz Mitoma, Franciso ^c   Sellors, John ^d   Shafran, Stephen D ^e  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b HEALTH SCIENCES CENTRE   (Canada)

^c CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

^d MCMASTER UNIVERSITY   (Canada)

^e UNIVERSITY OF ALBERTA   (Canada)

^f Viridae Clinical Sciences Inc ^*  (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FAMCICLOVIR;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; FEMALE; GENITAL HERPES; HEADACHE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; VERTIGO; VIRUS SHEDDING;

EID: 0029957145     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.276.1.44     Document Type: Article

References (34)

1. Corey L, Wald A. New developments in the biology of genital herpes. In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, eds. Clinical Management of Herpes Virus Infections. Amsterdam, the Netherlands: IOS Press; 1995:43-53.
2. Christenson B, Bottiger M, Svennson A, Jeannsen S. A 15-year surveillance study of antibodies to HSV-1&2 in a cohort of young girls. J Infect. 1992; 25:147-154.
3. Cunningham AL, Lee FK, Ho DWT, et al. Herpes simplex virus type 2 antibody in patients attending antenatal or STD clinics. Med J Aust. 1993; 158:525-528.
4. Johnson RE, Nahmias AJ, Madger LS, Lee FK, Brooks CA, Snowden CB. A seroepidemiological survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med. 1989;321:7-12.
5. Kinghorn GR. Epidemiology of genital herpes. J Int Med Res. 1994;22(suppl 1):14A-23A.
6. Sacks SL, Fox R, Levendusky P, et al. Chronic suppression for six months compared with intermittent lesional therapy of frequently recurrent genital herpes using oral acyclovir: effects on lesions and nonlesional prodromes. Sex Transm Dis. 1988;15:58-62.
7. Douglas JM, Critchlow C, Benedetti J, et al. A double-blind study of oral acyclovir for suppression of recurrences of genital herpes simplex virus infection. N Engl J Med. 1984;310:1551-1556.
8. Straus SE, Takiff HE, Seidlin M, et al. Suppression of frequently recurring genital herpes: a placebo-controlled double-blind trial of oral acyclovir. N Engl J Med. 1984;310:1545-1550.
9. Halsøs AM, Salo OP, Lassus A, et al. Oral acyclovir suppression of recurrent genital herpes: a double-blind, placebo-controlled, crossover study. Acta Derm Venereol Suppl. 1985;65:59-63.
10. Mindel A, Weller IV, Faherty A, et al. Prophylactic oral acyclovir in recurrent genital herpes. Lancet. 1984;2:57-59.
11. Gold D, Corey L. Acyclovir prophylaxis for herpes simplex virus infection. Antimicrob Agents Chemother. 1987;31:361-367.
12. Straus SE, Seidlin M, Takiff HE, et al. Double-blind comparison of weekend and daily regimens of oral acyclovir for suppression of recurrent genital herpes. Antiviral Res. 1986;6:151-159.
13. Goldberg LH, Kaufman R, Kurtz TO, et al, and the Acyclovir Study Group. Long-term suppression of recurrent genital herpes with acyclovir: a 5-year benchmark. Arch Dermatol. 1993;129:582-587.
14. Sacks SL. Treatment of herpes genitalis. In: De Clercq E, ed. Clinical Use of Antiviral Drugs. Boston, Mass: Martinus Nijhoff Publishing; 1988:87-114.
15. Sacks SL. Genital herpes simplex virus infection and treatment. In: Sacks SL, Straus SE, Whitley RJ, Griffiths PD, eds. Clinical Management of Herpes Virus Infections. Amsterdam, the Netherlands: IOS Press; 1995:55-74.
16. Sacks SL. The role of oral acyclovir in the management of genital herpes simplex. Can Med Assoc J. 1987;136:701-707.
17. Reichman RC, Badger GJ, Mertz GJ, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir: a controlled trial. JAMA 1984; 251:2103-2107.
18. Nilsen AE, Aasen T, Halsøs AM, et al. Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes. Lancet. 1982;2:571-573.
19. Pue MA, Benet LZ. Pharmacokinetics of famciclovir in man. Antiviral Chem Chemother. 1993; 4(suppl 1):47-55.
20. Vere Hodge RA. Famciclovir and penciclovir: the mode of action of famciclovir including its conversion to penciclovir. Antiviral Chem Chemother. 1993;4:67-84.
21. Boyd MR, Safrin S, Kern ER. Penciclovir: a review of its spectrum of activity, selectivity, and cross-resistance pattern. Antiviral Chem Chemother. 1993;4(suppl 1)3-11.
22. Vere Hodge RA, Perkins RM. Mode of action of 9-(4-hydroxy-3-hydroxymethylbut-1-yl) guanine (BRL 39123) against herpes simplex virus in MRC-5 cells. Antimicrob Agents Chemother. 1989;33:223-229.
23. Sacks SL, Teh CZ, Lemchuck-Favel L. Serotyping of herpes simplex virus isolates: a comparison of BVDU sensitivities, indirect immunofluorescence with monoclonal antibodies, and indirect immunofluorescnence with cross-adsorbed rabbit antibodies. J Virol Methods. 1983;7:199-206.
24. Cox DR. Regression models and life tables (with discussion). J R Stat Soc Ser B. 1972;34:187-220.
25. SAS Institute. SAS Procedures Guide, Version 6.07. Cary, NC: SAS Institute; 1988.
26. SAS Institute. SAS Technical Report P-229. Cary, NC: SAS Institute; 1982:433-479.
27. Hochberg Y. A sharper Bonferroni procedure for multiple tests of significance. Biometrika. 1988; 75:800-802.
28. Armitage P, Berry G. Statistical Methods in Medical Research. 2nd ed. Oxford, England: Blackwell Scientific Publications; 1987.
29. Sacks SL, Varner TL, Davies KS, et al. Randomized, double-blind, placebo-controlled, patient-initiated study of topical high- and low-dose interferon-α with nonoxynol-9 in the treatment of recurrent genital herpes. J Infect Dis. 1990;161: 692-698.
30. Sacks SL, Tyrrell DL, Lawee D, et al, and the Canadian Cooperative Study Group. Randomized, double-blind, placebo-controlled, clinic-initiated, Canadian multicenter trial of topical 3% edoxudine cream in the treatment of recurrent genital herpes. J Infect Dis. 1991;164:665-672.
31. Ruhnek-Forsbeck M, Sandstrom E, Andersson B, et al. Treatment of recurrent genital herpes simplex infections with oral acyclovir. J Antimicrob Chemother. 1985;16:621-628.
32. Salo OP, Lassus A, Hovi T, Fiddian AP. Double-blind placebo-controlled trial of oral acyclovir in recurrent genital herpes. Eur J Sex Transm Dis. 1983;1:95-98.
33. de Miranda P, Blum MR. Pharmacokinetics of acyclovir after intravenous and oral administration. J Antimicrob Chemother. 1983;12(suppl B): 29-37.
34. Sacks SL, Martel A, Aoki FY, Shafran SD, St-Pierre C, Lassonde M. Early, Clinic-Initiated Treatment of Recurrent Genital Herpes Using Famciclovir: Results of a Canadian, Multi-Center Study. Abstract presented at the Clinical Research Meeting, American Federation of Clinical Research; 1994; Baltimore, Md.